X

You're leaving www.fatty15.com and being redirected to an external site.

If the site does not reload after 5 seconds please copy and paste this link. https://www.seraphinatherapeutics.com/yourhealth.html

BREAKING NEWS: Fatty15 clinical trial results are in

✖

How helping dolphins may just save the world (and you, too)

Fatty15's origin story is now a TEDx talk, making it a darn good story worth sharing.

dolphins play

We’re partners — in life and purpose.

Two serial entrepreneurs, dedicated to service.

Stephanie Venn-Watson, DVM, MPH
  • CO-FOUNDER & CEO
  • Veterinary Epidemiologist.
  • Public Health Scientist.
  • 40 patents + 70 peer-reviewed scientific publications.
  • 2 decades of leading efforts to understand and improve dolphin health.
Eric Venn-Watson,
MD, MBA
  • CO-FOUNDER & COO
  • US Navy Veteran.
  • 20+ years as a Military Physician.
  • Launched and led 3 life science companies.
  • Supports entrepreneurship programs for military Veterans in San Diego.

Before fatty15™...

Stephanie served as an epidemiologist tracking diseases for the Centers for Disease Control and Prevention and the World Health Organization. She co-founded the National Marine Mammal Foundation and is a recipient of the Department of Health and Human Services Secretary’s Award for Innovations in Health Promotion and Disease Prevention.

Eric held multiple leadership roles as a US Navy military physician, with combat deployments to Iraq and Afghanistan. Experienced in growing companies with medical technologies, he was awarded the 'Best Entrepreneur' in the Startup Company Category at the Veteran and Military Conference and Awards.

Now back to the dolphins.

To see how these human-like mammals were affected by changes in the ocean and the fish they eat, we looked at two groups:

  • San Diego, CA
  • Sarasota, FL
But even though both populations were generally healthy, we noticed something strange.

A tale of two pods.

  • The California Pod

    More dolphins with aging-related conditions.

  • The Florida Pod

    Fewer dolphins with aging-related conditions.

And those aging-related conditions?
They’re the precursors to diabetes, heart disease and stroke in humans.

So what was the difference?

The Florida pod ate different fish than their California friends. Fish with higher levels of fatty acid C15:0 (aka FA15™).

When the California pod switched to fish with higher levels of C15:0 (aka FA15™), their aging-related conditions stabilized and their cells stabilized, too.

From fragile to sturdy.

After including more C15:0 (aka FA15™) in the California pod’s diet, we saw a 72% improvement in cellular stability.

See the study.

So could improving the lives of dolphins help humans, too?

And could helping humans...help dolphins in the wild?

“Yes”

- The consortium of scientists, doctors, dreamers and innovators continuously working to improve global health.

Bottlenose dolphins are a lot like us.

They live for a long time. They’re social and intelligent. And they can develop aging-related conditions.

But with our fatty15 breakthrough, we’re just getting started helping both humans and dolphins age in healthier ways.*

We believe that if we can impact health at its core, we can change the world from the inside, out.

The team behind the vision.

Society spent a generation avoiding fat, we’ve dedicated our lives to harnessing it.

i
Stephanie Venn-Watson, DVM, MPH

CEO, Co-Founder
i
Eric Venn-Watson, MD, MBA

COO, Co-Founder
i
Kim Kamdar, PhD

Board Chair, Co-Founder
i
Nicholas Schork, PhD

Senior Scientist, Co-Founder
Chris Doyle

Chief Financial Officer
Dennis Bernstein, MBA

VP of Retention & Lifecycle Marketing
Ali Bernstein

Head of Consumer Experience & Engagement
Bear Buscher

Head of Healthcare Sales and Wholesale Operations
i
Kate McMahon

Sr. Account Manager
i
Edward Dennis, PhD

Scientific Advisor
i
Ronald Krauss, MD

Scientific Advisor
Daniel Einhorn, MD

Medical Advisor, Endocrinology
Stephanie Venn-Watson, DVM, MPH
CEO, Co-Founder

Steph is a serial entrepreneur of for-profit and not-for-profit companies, a veterinary epidemiologist and public health scientist with over 40 patents and 70 peer-reviewed scientific publications, and previously served as an epidemiologist tracking diseases for the Centers for Disease Control and Prevention and World Health Organization.

Eric Venn-Watson, MD, MBA
COO, Co-Founder

Eric is a practicing physician and entrepreneur. He served over 25 years as a Navy and Marine Corps physician, working with the special forces community to improve their health and fitness. Additionally, Eric founded multiple companies in the drug discovery, healthcare analytics, and medical device industries. He is passionate about developing medical technologies that improve the practice and delivery of healthcare on a global scale.

Kim Kamdar, PhD
Board Chair, Co-Founder

Kim is a Managing Partner of Domain Associates, a life sciences venture capital firm, and has been involved in numerous cutting-edge therapeutic start-ups. She was also a research director at Novartis, where she led a team to uncover small molecules that modulated signaling pathway networks.

Nicholas Schork, PhD
Senior Scientist, Co-Founder

Nicholas is a Distinguished Professor and Director of the Quantitative Medicine and Systems Biology Division at Translational Genomics Institute, an affiliate of The City of Hope. In addition, as a leader in the design and analysis of studies of longevity, Nicholas is Scientific Director for the National Institute of Health’s National Institute of Aging-sponsored Longevity Consortium.

Chris Doyle
Chief Financial Officer

Chris is a finance leader focused on driving scale and profitability for high-growth businesses. Throughout his career, Chris has worked with both small and large companies to develop growth strategies, navigate operational hurdles, execute M&A transactions, and raise capital. He is passionate about developing data-driven insights to support long-term, sustainable business expansion. Chris began his career in investment banking at J.P. Morgan and Moelis, and he has held finance roles at Mars Wrigley, KIND and Diggs.


Dennis Bernstein, MBA
VP of Retention & Lifecycle Marketing

Dennis is a marketing and brand builder, with an entrepreneurial mindset.  He has 20+ years of experience leading the development of innovative brands and launching successful consumer products into the marketplace, working at some of the most rapidly evolving Omni-channel and DTC companies, including Procter & Gamble and Dollar Shave Club. Dennis developed and led such projects as the Thank you Mom campaign for the London Olympics and global launches for the Crest/Oral B and Gillette brands.

Ali Bernstein
Head of Consumer Experience & Engagement

Ali is an expert when it comes to marketing and community building, with the number one priority of always putting the customer first. Ali's mission is to make customers’ feel like friends and part of the fatty15 family, helping people with any requests. With over 23+ years of marketing experience on both the agency and client side of the business building communities, at companies like Empower MediaMarketing, Ali enjoys bringing her personable nature to the fatty15 family.

Bear Buscher
Head of Healthcare Sales and Wholesale Operations

Bear is a sales leader with over a decade of experience in consistently achieving remarkable results across diverse consumer packaged goods (CPG) sectors. Throughout his career, Bear has orchestrated the successful introduction of over 70 distinct consumer products across multiple brands, spanning various consumer industries. In addition, he has guided and mentored multiple award-winning cross-functional teams, fostering a strong foothold and reputation in the wellness industry and beyond.

Kate McMahon
Sr. Account Manager

Kate is a highly motivated professional experienced in non-profit fundraising, event and project management. With her leadership, organizational skills, effective communication, and optimistic attitude, she is an invaluable asset as our project manager. She excels in maintaining a holistic perspective while also paying meticulous attention to detail. Kate proactively seeks opportunities to improve and enhance processes for the benefit of the entire team.

Living abroad as a military family has honed her change management abilities and broadened her global perspective, fueling her desire to work for companies that make a positive impact on people's lives. She finds immense satisfaction in her role at Seraphina Therapeutics, where she actively contributes to their mission of advancing global health through the transformative fatty acid C15:0.

Edward Dennis, PhD
Scientific Advisor

Ed is a Distinguished Professor of Chemistry, Biochemistry and Pharmacology specializing in lipid research at the University of California San Diego School of Medicine. Ed, who is a graduate of Yale University and Harvard University, was Editor-in-Chief of the Journal of Lipid Research and has 375 peer-reviewed publications, including roles of fatty acids in health.

Ronald Krauss, MD
Scientific Advisor

Ron is a Senior Scientist and Director of Atherosclerosis Research at Children's Hospital Oakland Research Institute and Adjunct Professor in the Department of Medicine at UCSF and the Department of Nutritional Sciences at UC Berkeley. Ron is a graduate of Harvard University, is board-certified in internal medicine, endocrinology and metabolism, and is a Fellow of the American Society of Nutrition and American Heart Association. He has 450 peer-reviewed publications, including leading papers on dairy-based fats and health.

Daniel Einhorn, MD
Medical Advisor, Endocrinology

Dr. Einhorn is the president of the American Association of Clinical Endocrinologists, medical director of the Scripps Whittier Diabetes Institute and Clinical Professor of Medicine at UCSD. He is an editor and contributor to numerous books and articles, including publications from the American Medical Association and the Royal Society of Medicine, and has been a teacher in graduate medical education throughout the world.